logo

Last Update

This profile was last updated on 8/1/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Steven Paul?

Steven M. Paul

Scientific Director

National Institute of Mental Health

HQ Phone:  (301) 443-4513

Email: s***@***.gov

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

National Institute of Mental Health

6001 Executive Blvd

Bethesda, Maryland,20892

United States

Company Description

The National Institute of Mental Health (NIMH), part of the U.S. National Institutes of Health (NIH), is the largest scientific organization in the world dedicated to mental health research. NIMH is one of 27 Institutes and Centers of the NIH, the world's lead...more

Background Information

Employment History

Director

Charlie Rose Inc


Affiliations

American Association for the Advancement of Science

Fellow


Institute of Medicine

Member


Seaside Therapeutics LLC

Board Member


Eli Lilly and Company

Executive Vice President, Science and Technology, President


PsychoGenics Inc

Scientific Advisory Board Member


Alnylam Pharmaceuticals , Inc.

Board Member


Xconomy Inc

Board Member


Foundation for the National Institutes of Health Inc

Board Member


Sage Therapeutics, Inc.

Board Member


Sigma-Aldrich Corporation

Board Member


The MIND Institute

Trustee


National Academy of Medicine

Member


National Advisory Mental Health Council

Member


Foundation for the NIH

Trustee


Board

Member


Phi Eta Sigma

Member


Excalibur Group Holdings Limited

Scientific Advisor


Corporate Ex..

Executive Vice President of Science and Technology and A Member


The Biomarkers Consortium

Chairman of the Consortium Executive Committee


PhRMA Foundation

Executive Board of Regulatory Committee


Butler University

Board Member


Indianapolis Zoological Society

Board Member


Regulatory Committee

Executive Board of Regulatory Committee


Cerecor Inc.

Scientific Advisory Board Member


American College of Neuropsychopharmacology

Fellow


Pritzker Neuropsychiatric Disorders Research Consortium

Scientific Advisory Board Member


Science and Technology

Position In Compensation Committee


Stern Investor Relations , Inc.

Board Member


Scientific Advisory Board

Founder


SAB

Founder


Cell Therapy News

Board Member


Research Bank

Board Member


Project

Board Member


NorthCarolinaLifeScience.com

Board Member


Mind Research Network

Board of Trustees Member


Chemical & Engineering News

Board Member


Neuroscience and Behavior

Board Member


Constellation Pharmaceuticals , Inc.

Board Member


BioCrossroads company

Board Member


Alpha Omega Alpha

Member


Biotechnology Industry Organization

Board Member


The REACH Institute

Board Member


NIMH/NIH

Member of the Advisory Committee To the Director


Collegium Internationale Neuro-Psychopharmacologicum

Fellow


The American College of Psychiatrists

Fellow


Karuna Pharmaceuticals

Founder and Chief Executive Officer and Scientific Advisory Board Member of Tal Medical and Chairman of Directors


National Investor Relations Institute

Board Member


U.S. National Institutes of Health

Member, Advisory Committee


Simons Foundation

Member, Scientific Advisory Board


Conkwest Inc

Board Member


ViaCell , Inc.

Board Member


Knowledge Decisions , LLC

Board Member


Education

Bachelor of Arts degree

Biology and Psychology

Tulane University


Doctor of Medicine degree

Tulane University School of Medicine


M.D.

Weill Cornell Medical College


M.D. Executive Vice President

National Institute of Mental Health


MD

Emory University


MD

MassGeneral Institute for Neurodegenerative Diseases


Master of Science

Tulane University School of Medicine


Web References(176 Total References)


Board of Directors | Seaside Therapeutics

www.seasidetherapeutics.com [cached]

Steven M. Paul, MD
Dr Paul holds a position as a director of the Allen Institute for Brain Sciences and the Foundation of the National Institutes of Health. Dr. Paul is a graduate of Tulane University graduated holding a MS in anatomy and neuroanatomy and a MD. Dr. Paul has worked in the pharmaceutical industry for almost 4 decades. Before becoming part of Lilly, Dr. Paul held a position as the scientific director of the National Institute of Mental Health. He has published more than 500 research papers and invited book chapters. He is the editor for a plethora of scientific journals. He is a member of the Institute of Medicine of the National Academy of Sciences and a Fellow of the American Association for the Advancement of Science.


Scientific Advisory Board | PsychoGenics

psychogenics.com [cached]

Steven Paul, M.D.
Dr. Steven Paul is the recently retired Executive Vice President and President of the Lilly Research Laboratories of Eli Lilly and Company. Prior to this position, Dr. Paul was Group Vice President of Discovery Research and Clinical Investigation as well as Vice President of Neuroscience Discovery Research at Lilly. In his role as Lilly's R&D leader Dr. Paul oversaw the R&D efforts of over 8,000 scientists and physician investigators. Prior to assuming his position at Lilly, Dr. Paul served as the Scientific Director of the National Institute of Mental Health (NIH). Dr. Paul is a neuropsychopharmacologist and psychiatrist by training and his own research has focused on novel therapeutic interventions for Alzheimer's disease, depression and schizophrenia. Among his many scientific contributions has been the delineation of the role for the inhibitory neurotransmitter GABA in mediating the behavioral effects of benzodiazepines, barbiturates, short-chain alcohols and a novel class of neuroactive steroids. Dr. Paul has published over 500 papers and invited book chapters and holds 8 patents on inventions made at Lilly and NIH and is an inventor of solanezumab one of Lilly's late-stage drug candidates for Alzheimer's disease.


FNIH Board Elects Steven M. Paul, M.D., as New Chairman | FNIH

fnih.org [cached]

FNIH Board Elects Steven M. Paul, M.D., as New Chairman | Read More
FNIH Board Elects Steven M. Paul, M.D., as New Chairman | FNIH FNIH Board Elects Steven M. Paul, M.D., as New Chairman BETHESDA, MD, June 28, 2016 - The Board of Directors of the Foundation for the National Institutes of Health (FNIH) has unanimously elected Board member Steven M. Paul, M.D., as the new Chairman. Dr. Paul's term began immediately following the May 19, 2016 Board meeting. Dr. Paul succeeds Charles A. Sanders, M.D., who has served as Chairman since 1997 and will remain a member of the Board. "It is an honor to be selected as the next Chairman of the FNIH, knowing I will have large shoes to fill following Charlie's dynamic leadership," said Dr. Paul. "I am humbled by the trust shown by my fellow Board members and look forward to working with our talented staff to propel biomedical research and innovation that supports the NIH mission to benefit patients here and around the world." With a career that spans industry, government and academia, Dr. Paul has more than 35 years of experience in neuroscience, drug discovery and development. Dr. Paul is President and Chief Executive Officer at Voyager Therapeutics, Inc., as well as a Venture Partner at Third Rock Ventures. At Voyager, he leads the development of life-changing gene therapy treatments for fatal and debilitating diseases of the central nervous system. One of the most highly-cited neuroscientists in the world, Dr. Paul has authored more than 550 papers and book chapters. "I am delighted to see Steve assume the role of Chairman at the Foundation," said Dr. Sanders. Prior to Voyager, Dr. Paul was the Founding Director of the Helen and Robert Appel Alzheimer's Disease Research Institute, the Burton P. and Judith B. Resnick Distinguished Professor in Neurodegenerative Diseases and a DeWitt Senior Scholar and Professor of Neuroscience, Psychiatry and Pharmacology at Weill Cornell Medical College. Dr. Paul spent 17 years at Eli Lilly and Company, where he was President of the Lilly Research Laboratories. Prior to Eli Lilly, Dr. Paul served as Scientific Director of the National Institute of Mental Health and Medical and Director in the Commissioned Corps of the United States Public Health Service (USPHS). He is a member of the National Academy of Medicine and serves on the boards of Alnylam Pharmaceuticals, SAGE Therapeutics and formerly the Sigma Aldrich Company. Dr. Paul holds a B.A. in biology and psychology from Tulane University and an M.S. and M.D. from the Tulane University School of Medicine.


Our Team - SAGE Therapeutics

www.sagerx.com [cached]

Steven Paul, M.D.
Steven has had a distinguished career in neuroscience, particularly in CNS drug discovery and development. Steven is the former President of the Lilly Research Laboratories of Eli Lilly and Company and now leads the Helen & Robert Appel Institute for Alzheimer's Research at Weill Cornell Medical College. Prior to his appointment at Weill Cornell, Steven spent 17-years at Eli Lilly, during which time he held several key leadership roles, including Vice President of Neuroscience (CNS) Research and Group Vice President of Discovery Research (all therapeutic areas). In his most recent role, he was responsible for the company's overall research and development efforts - helping to expand Lilly's R&D efforts in oncology and biotechnology - resulting in a pipeline of approximately 70 new molecular entities. Prior to Lilly, Steven served as Scientific Director of the National Institute of Mental Health. He has also served as Medical Director in the Commissioned Corps of the United States Public Health Service. Steven has been the recipient of many awards and honors and has served on numerous committees and advisory boards. He has also authored or co-authored more than 500 papers and book chapters. Steven is an elected fellow of the American Association for the Advancement of Science and a member of the Institute of Medicine of the National Academy of Sciences. He is also currently on the board of directors or is a trustee of several organizations, including the Sigma-Aldrich Corporation, Alnylam Pharmaceuticals, Allen Institute for Brain Science, The Mind Research Network and the Foundation for the NIH. Dr. Paul has also served as a member of the National Institute of General Medical Sciences (NIGMS) Advisory Council and was appointed by the Secretary of the Department of Health and Human Services (HHS) as a member of the advisory committee to the Director of the NIH from 2001-2006. Steven is currently a member of the National Advisory Mental Health Council, NIMH, and is board certified by the American Board of Psychiatry and Neurology. Steven received his B.A. in Biology and Psychology from Tulane University, and his M.S. and M.D. degrees from the Tulane University School of Medicine.


Audit Committee Charter - Sage Therapeutics, Inc.

investor.sagerx.com [cached]

Steven Paul, MD
Steven Paul, MD Steven Paul has had a distinguished career in neuroscience, particularly in CNS drug discovery and development. Dr. Paul is the former President of the Lilly Research Laboratories of Eli Lilly and Company and now leads the Helen & Robert Appel Institute for Alzheimer's Research at Weill Cornell Medical College. Prior to his appointment at Weill Cornell, Dr. Paul spent 17-years at Eli Lilly, during which time he held several key leadership roles, including Vice President of Neuroscience (CNS) Research and Group Vice President of Discovery Research (all therapeutic areas). In his most recent role, he was responsible for the company's overall research and development efforts - helping to expand Lilly's R&D efforts in oncology and biotechnology - resulting in a pipeline of approximately 70 new molecular entities. Prior to Lilly, Dr. Paul served as Scientific Director of the National Institute of Mental Health. He has also served as Medical Director in the Commissioned Corps of the United States Public Health Service. Dr. Paul has been the recipient of many awards and honors and has served on numerous committees and advisory boards. He has also authored or co-authored over 500 papers and book chapters. Dr. Paul is an elected fellow of the American Association for the Advancement of Science and a member of the Institute of Medicine of the National Academy of Sciences. He is also currently on the board of directors or is a trustee of several organizations, including the Sigma-Aldrich Corporation, Alnylam Pharmaceuticals, the Allen Institute for Brain Sciences, The Mind Research Network and the Foundation for the NIH. Dr. Paul has also served as a member of the National Institute of General Medical Sciences (NIGMS) Advisory Council and was appointed by the Secretary of the Department of Health and Human Services (HHS) as a member of the advisory committee to the Director of the NIH from 2001-2006. Dr. Paul is currently a member of the National Advisory Mental Health Council, NIMH, and is board certified by the American Board of Psychiatry and Neurology. Dr. Paul received his B.A. in Biology and Psychology from Tulane University, and his M.S. and M.D. degrees from the Tulane University School of Medicine.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory